Pipamperone dihydrochloride
SIGMA/P3246 - ~99% (HPLC), powder
Synonym: 1′-[4-(4-Fluorophenyl)-4-oxobutyl]-[1,4′-bipiperidine]-4′-carboxamide dihydrochloride; R4050
CAS Number: 2448-68-2
Empirical Formula (Hill Notation): C21H30N3O2F · 2HCl
Molecular Weight: 448.40
EC Number: 219-507-5
MDL Number: MFCD00242980
Linear Formula: C21H30N3O2F · 2HCl
Product Type: Chemical
| assay | ~99% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C21H30FN3O2.2ClH/c22-1 |
| InChI key | BMXXSXQVMCXGJM-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 100 ![]() |
| SMILES string | Cl[H].Cl[H].NC(=O)C1(CCN( |
| solubility | H2O: >2.0 mg/mL |
| Application: | Pipamperone dihydrochloride may be used: • as an internal standard in liquid chromatography with coulometric detection • as an antipsychotic drugs to test its interaction with human ether-a-go-go-related gene (hERG) channel • as an internal standard to spike human colostrum samples for reversed phase liquid chromatography- ultraviolet (LC-UV) analysis |
| Biochem/physiol Actions: | D2 dopamine receptor antagonist; 5-HT2 serotonin receptor antagonist; antipsychotic. |
| Biochem/physiol Actions: | Pipamperone, a butyrophenone derivative is a pharmacological chaperone and is a membrane-permeable dopamine receptor D4 (DRD4) antagonist. The affinity of pipamperone is higher for DRD4 and 5-hydroxytryptamine 2A receptor (5-HT2A) in comparison with DRD2. It may be useful therapeutic in treating behavioral disorders and psychomotor agitation symptoms. |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 100 mg in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Purity | ~99% (HPLC) |
| UNSPSC | 12352200 |


